349 related articles for article (PubMed ID: 22375056)
1. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.
Tibarewal P; Zilidis G; Spinelli L; Schurch N; Maccario H; Gray A; Perera NM; Davidson L; Barton GJ; Leslie NR
Sci Signal; 2012 Feb; 5(213):ra18. PubMed ID: 22375056
[TBL] [Abstract][Full Text] [Related]
2. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
3. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
Steelman LS; Navolanic PM; Sokolosky ML; Taylor JR; Lehmann BD; Chappell WH; Abrams SL; Wong EW; Stadelman KM; Terrian DM; Leslie NR; Martelli AM; Stivala F; Libra M; Franklin RA; McCubrey JA
Oncogene; 2008 Jul; 27(29):4086-95. PubMed ID: 18332865
[TBL] [Abstract][Full Text] [Related]
4. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity.
Errafiy R; Aguado C; Ghislat G; Esteve JM; Gil A; Loutfi M; Knecht E
PLoS One; 2013; 8(12):e83318. PubMed ID: 24349488
[TBL] [Abstract][Full Text] [Related]
5. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia.
Zhiyong C; Wentong L; Xiaoyang Y; Ling P
Med Oncol; 2012 Jun; 29(2):1084-92. PubMed ID: 21360018
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.
Davidson L; Maccario H; Perera NM; Yang X; Spinelli L; Tibarewal P; Glancy B; Gray A; Weijer CJ; Downes CP; Leslie NR
Oncogene; 2010 Feb; 29(5):687-97. PubMed ID: 19915616
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
8. PTEN inhibits BMI1 function independently of its phosphatase activity.
Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
[TBL] [Abstract][Full Text] [Related]
9. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
[TBL] [Abstract][Full Text] [Related]
10. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
11. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
12. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D
Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress.
Maccario H; Perera NM; Gray A; Downes CP; Leslie NR
J Biol Chem; 2010 Apr; 285(17):12620-8. PubMed ID: 20177066
[TBL] [Abstract][Full Text] [Related]
14. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling.
He J; de la Monte S; Wands JR
Biochem Biophys Res Commun; 2010 Jul; 397(3):513-9. PubMed ID: 20515662
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU
Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612
[TBL] [Abstract][Full Text] [Related]
17. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
18. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
19. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
20. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]